Showing 4081-4090 of 10627 results for "".
New Evidence on Biologics in Severe Asthma with Normal Lung Function
https://reachmd.com/programs/clinicians-roundtable/biologics-severe-asthma-normal-lung-function/54179/Optimizing Vitamin D Supplementation in MS Care
https://reachmd.com/programs/neurofrontiers/vitamin-d-supplementation-ms/54244/Managing Unexpected Aesthetic Changes Associated with the Use of GLP-1 Receptor Agonists
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/managing-unexpected-aesthetic-changes-associated-with-the-use-of-glp-1-receptor-agonists/54441/Laser-Assisted Drug Delivery
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/laser-assisted-drug-delivery/54438/Understanding Thyroid Hormone Dynamics After COVID-19 Infection
https://reachmd.com/programs/clinicians-roundtable/thyroid-hormone-dynamics-covid-19/48833/How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
https://reachmd.com/programs/clinicians-roundtable/covid-19-vaccination-immune-checkpoint-inhibitors/48832/The Case for Doing the Hard Thing
https://reachmd.com/topics/practice-development/the-case-for-doing-the-hard-thing/49010/GA Case Compendium: Patient Education, Advanced Technologies, and Timely Referrals Are Crucial in Geographic Atrophy
https://reachmd.com/resources/geographic-atrophy-case-compendium/ga-case-compendium-patient-education-advance-technologies-and-timely-referrals-are-crucial-in-geographic-atrophy/48920/Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
https://reachmd.com/clinical-practice/cardiology/evolocumab-in-patients-at-high-cardiovascular-risk-without-prior-mi-or-stroke-primary-results-of-the-vesalius-cv-trial/39889/Explore VESALIUS-CV trial results on evolocumab for cardiovascular risk reduction in patients without prior MI or stroke who are at high cardiovascular risk.AIP Emerges as a Potential Marker for Diabetic Kidney Risk
https://reachmd.com/programs/clinicians-roundtable/aip-emerges-as-a-potential-marker-for-diabetic-kidney-risk/37220/